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A humanized mouse model for 
sequestration of Plasmodium 
falciparum sexual stages and in vivo 
evaluation of gametocytidal drugs
Yoann Duffier1,2,3,4, Audrey Lorthiois1,2,3,4, Pau Cisteró5, Florian Dupuy1,2,3,4, Grégory Jouvion6, 
Laurence Fiette6, Dominique Mazier7,8, Alfredo Mayor5, Catherine Lavazec1,2,3,4,9,* & 
Alicia Moreno Sabater7,10,*
The development of new drugs to disrupt malaria transmission requires the establishment of an in vivo  
model to address the biology of Plasmodium falciparum sexual stages (gametocytes). Herein we 
show that chemically immune-modulated NSG mice grafted with human erythrocytes support 
complete sexual development of P. falciparum parasites and generate high gametocytemia. 
Immunohistochemistry and RT-qPCR analyses indicate an enrichment of immature gametocytes in 
the bone marrow and the spleen, suggesting a sequestration mechanism reminiscent to that observed 
in humans. Upon primaquine treatment, elimination of gametocytes from peripheral blood and from 
sequestration sites was observed, providing a proof of concept that these mice can be used for testing 
drugs. Therefore, this model allows the investigation of P. falciparum sexual commitment, gametocyte 
interactions with the bone marrow and spleen and provides the missing link between current in vitro 
assays and Phase I trials in humans for testing new malaria gametocytidal drugs.
The eradication of malaria requires the development of new transmission-blocking drugs that have to be tested 
in animal models1. Plasmodium falciparum transmission from humans to mosquitoes is ensured by the parasite 
sexual stages called gametocytes. Immature gametocytes, from stage I to IV, develop in erythrocytes that seques-
ter approximately 10 days in internal organs. Only the mature stages (stage V) are found in the peripheral blood 
where they are available for ingestion by mosquitoes. Recent molecular and histological studies of post-mortem 
specimens and clinical studies from infected individuals revealed that immature gametocytes are present in the 
extravascular compartment of the human bone marrow2–4. In addition, early post-mortem observations and a 
recent clinical case report on a splenectomized patient suggested that immature gametocytes might also sequester 
in the spleen5–7. However, it is still unclear whether the spleen is a site for maturation or clearance of immature 
gametocytes. The molecular mechanisms underlying the sequestration of gametocytes, followed by their release 
upon maturation into the circulation, remains one of the unanswered questions in the biology of malaria parasites 
that needs to be addressed by in vivo studies8.
One of the major challenges in studying P. falciparum gametocytes in laboratory animals is the parasite’s 
specificity for its human host and the important biological differences that exist between P. falciparum and rodent 
malaria gametocytes. Moreover, the use of non-human primates is limited due to economic and ethical consid-
erations. In addition, P. falciparum infection with a gametocyte-producing parasite strain can only be achieved in 
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splenectomized animals9,10, precluding the use of monkeys to address gametocytes’ interactions with the spleen. 
Consequently, mechanisms underlying P. falciparum gametocytogenesis have never been addressed in vivo. In 
addition, the lack of appropriate experimental models has restricted the evaluation of new transmission-blocking 
drugs to in vitro assays, which do not account for factors such as drug metabolism or gametocyte sequestration 
that might complicate intervention approaches. The generation of mouse strains with severe immunodeficiency 
and grafted with human red blood cells (hRBC) has allowed the establishment of humanized mouse models for 
P. falciparum erythrocyte infection that are currently being used to test anti-malarial drugs that target asexual 
parasites11,12. Further development of transgenic immune-deficient mice has made it possible to study the parasite 
pre-erythrocytic cycle and the complete life cycle was obtained in mice co-grafted with human hepatocytes and 
hRBC13,14. However, parasite sexual development in these humanized mouse models is still challenging due to 
the high turnover rate of infected hRBC, which is not optimal for the complete maturation of gametocytes. A few 
authors have reported presence of gametocytes in peripheral blood of P. falciparum-infected humanized mice, 
however gametocytes were only detected at very low levels (below 0.001%)13,15,16. High gametocytemia have only 
been reported when mouse splenic function was reduced by splenectomy17 or by using an immunomodulation 
protocol that led to gametocyte formation and maturation in the peritoneum11,18. Consequently, these models 
have not been developed further and to date there are no reports describing their usefulness to test the ability of 
compounds to eliminate P. falciparum gametocytes, nor their relevance as a model to address gametocyte interac-
tions with the bone marrow and the spleen.
To overcome the limitations of these humanized models, we optimized an immunosuppression protocol to 
decrease the macrophage load in the spleen and liver18, thereby increasing the half-life of grafted hRBC and 
allowing gametocyte sequestration in internal organs. We applied this protocol to the severe immune-deficient 
mouse strain NOD SCID gamma c (NSG) and followed gametocyte development and distribution in different 
mice organs after P. falciparum infection.
Results and Discussion
In previous reports we have shown that an immunomodulation protocol in immune-deficient mice allows the 
engraftment of hRBC and subsequent P. falciparum infection by intraperitoneal route18,19. In this protocol, the 
depletion of neutrophils and macrophages in the peritoneum, the spleen and the liver was induced by NIMP-R14 
mAb and by clodronate encapsulated in liposomes (lip-clod), respectively. However, the high concentrations of 
NIMP-R14 mAb and lip-clod used in this protocol resulted in hRBC retention in the mouse peritoneum and 
consequently a high proportion of hRBC did not reach the peripheral blood, leading to gametocyte formation 
and maturation in the peritoneum11,18. This artificial model did not reflect P. falciparum gametocyte development 
in humans and precluded its use to address gametocyte interactions with host organs. To improve hRBC engraft-
ment in peripheral blood, we optimized a new immunosuppression protocol in the severe immune-deficient 
mouse strain NOD SCID gamma c (NSG) (Fig. 1a). This mouse strain lacks mature T cells, B cells and Natural 
Killer cells, and is an excellent recipient mouse model for engraftment of human cells15,20. To overcome hRBC 
retention in mouse peritoneum, we tested three different combinations of lip-clod and mAb NIMP-R14 (Fig. 1b). 
Our results showed that the combination of 6.25 mg/kg of lip-clod, 1 mg/kg of NIMPR-14 and 0.75 mL of hRBC 
allowed the graft of human cells in peripheral blood without residual retention in peritoneum. This combination 
also reduced mouse mortality without inducing any major changes in other hematological parameters (Fig. 1b). 
Eighteen NSG mice were humanized with this immunomodulation protocol and infected with P. falciparum 
asexual parasites in four independent experiments (Fig. 1a). The parasitemia and gametocytemia were monitored 
daily in thin tail-blood smears from day 3 post infection (dpi) until sacrifice at different time points. Asexual 
parasites were detected in the peripheral circulation of the 18 mice and gametocytes at different stages of matu-
rity (stage I to V) were observed in 15 mice (Fig. 2a), with peaks of gametocytemia ranging from 0.042% to 1% 
(Fig. 2b,e). During the course of gametocyte development, engraftment of hRBC in peripheral blood increased 
from 50% to 85% whereas other hematological parameters remained stable (Fig. 2c,d). Appearance of stage II 
gametocytes in the peripheral blood occurred on average 8 days after injection of asexual parasites and stage I 
gametocytes were still observed up to 35 days post-infection (Fig. 2e). These results indicate that parasite sexual 
commitment occurred in mice rather than in vitro prior to injection, thus supporting the use of this humanized 
mouse model to address in vivo the mechanisms underlying gametocytogenesis.
To evaluate whether this new immunosuppression protocol in NSG mice allows the parasite to sequester 
and mature in the spleen and bone marrow, we investigated the parasite distribution in different mouse organs. 
Immunohistochemical labeling was performed on samples of bone marrow, spleen, liver and lung of 5 mice 
with antibodies against the constitutively expressed heat shock protein 70 (HSP70), that detects all parasites, or 
the gametocyte specific antigen Pfg27 that detects stage I to stage V gametocytes21 (Fig. 3a). The proportion of 
gametocytes in the parasite population was 2 to 3-fold higher in the bone marrow and spleen than in the lung and 
liver (Fig. 3b). To further confirm this observation, we performed a real-time RT-qPCR analysis to measure gene 
expression of the gametocyte specific gene Pfs48/45 related to the asexual stage specific genes hypoxanthine phos-
phorybosyltransferase (hprt) and skeleton binding protein 1 (sbp1) in peripheral blood, bone marrow, spleen, liver 
and lung of 8 mice (Fig. 3c). The mean expression of Pf48/45 was about 3-fold higher in the bone marrow and 
spleen compared to peripheral blood, lung and liver. This indicates that gametocytes were more abundant in the 
bone marrow and spleen than in peripheral blood and other organs, in agreement with the immunohistochem-
ical analysis. To determine the spatial distribution of parasites within the bone marrow, sternum bone marrow 
sections were stained with anti-laminin antibody to label the basement membrane of the host vasculature22 and 
hemozoin malaria pigments were localized relative to the laminin-positive microvasculature (Fig. 3d). In three 
mice with 54–65% gametocytes in their bone marrow, as determined by the ratio Pfg27/HSP70, we observed 
an average of 47% of parasites associated with laminin and 53% in the extravascular space (Fig. 3e). Although 
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presence of hemozoin pigments is not specific for gametocytes, these observations suggest that a proportion of 
gametocytes were enriched in the extravascular compartment of bone marrow, as observed in humans4.
To address the distribution of each gametocyte stage in the bone marrow and spleen compared to periph-
eral blood, we performed an immunostaining analysis using an antibody against the gametocyte marker Pfg27 
on smears of peripheral blood, bone marrow aspirate, and spleen extract (Fig. 4a). Results showed that only 
immature gametocytes from stage I to III were significantly enriched in the bone marrow and spleen, whereas 
mature gametocytes were more abundant in the peripheral blood (Fig. 4b–d). These results suggest that imma-
ture gametocytes sequester in the bone marrow and spleen of these mice and are released into the circulation 
upon maturation, although enrichment of gametocytes in the spleen may also reflect their retention in splenic 
slits before clearance by macrophages. In either case, our results are in accordance with observations made in 
humans2,4,7. However, the observation that one third of the immature gametocyte population is present in the 
peripheral circulation suggests that the sequestration mechanism occurring in this mouse model is incomplete. 
A possible explanation is that gametocyte sequestration in humans may be due to a combination of cytoadhesion 
and mechanical retention mechanisms, and the lack of human specific receptor(s) in NSG mice might only allow 
rigidity-mediated sequestration due to the important stiffness of immature gametocyte-infected erythrocytes23. 
Figure 1. Establishment of a new protocol for Plasmodium falciparum sexual development in humanized 
mouse. (a) Experimental procedure for engraftment of NSG mice with hRBC before infection with P. falciparum 
parasites. (b) Hematological parameters and mortality in 4 groups of mice (n = 4 mice per group) treated with 
different immunomodulation protocols. Protocol A: 33.3 mg/kg of lip-clod + 10 mg/kg of mAb NIMP-R14, 
protocol B: 13.3 mg/kg of lip-clod + 2 mg/kg of mAb NIMP-R14 and protocol C: 6.25 mg/kg of lip-clod + 1 mg/kg 
of mAb NIMP-R14. Control mice received RPMI 1460 medium. Measurement of total RBC (mouse and human 
RBC, 106/mm3), platelets (PLT, 103/mm3), leucocytes (LCT, 103/mm3), hematocrit (HTC, %) and percentage of 
hRBC (hRBCpb) in mice peripheral blood samples were performed by using an automatic hematology analyzer 
at day 9 of the protocol. Mortality was recorded during 9 days and surviving mice (4 in Control group, 3 in 
group A, 2 in group B and 4 in group C) were sacrificed at day 9. Presence of hRBC in peritoneum (hRBCp) was 
determined after sacrifice. Complete coverage of this cavity with hRBC was noted as 2 points, partial coverage 
was noted as 1 point and absence of hRBC was noted as 0 point.
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The development of a long-term humanized mouse model with human bone marrow transplantation would allow 
to decipher the putative respective roles of cytoadhesion and mechanical retention in sequestration mechanisms. 
Figure 2. P. falciparum gametocytes develop in humanized NSG mice. (a) Representative pictures of stage II, 
III, IV and V gametocytes in peripheral blood as observed in Giemsa-stained thin blood smears. Bars represent 
2 μ m. (b) Kinetics of gametocytemia for stage II, III, IV and V gametocytes in peripheral blood during 35 days 
of infection. Results represent the average gametocytemia of 15 mice from 4 independent infection experiments. 
Mice were sacrificed at different time points (3 mice at day 10, 5 mice at day 14, 5 mice at day 19 and 2 mice at 
day 35). (c,d) Follow up of hematological parameters in 8 mice during gametocyte development. Measurement 
of platelets, leucocytes, hematocrit and % of hRBC in mice peripheral blood samples were performed with 
an automatic hematology analyzer. (e) Kinetics of asexual stages and gametocytes in peripheral blood during 
the course of infection. Parasitemia, gametocytemia (% of parasites in total RBCs) and prepatent period 
(time between inoculation and detection of parasites on thin blood smears) for each gametocyte stage were 
determined by counting parasites on Giemsa-stained thin blood smears. Data represent the average of 15 mice 
from four independent infection experiments. dpi: days post-infection.
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Altogether these exciting observations indicate that this humanized mouse model provides a unique opportunity 
to address in vivo the mechanisms underlying sequestration of immature gametocytes in human bone marrow 
and potentially in the spleen.
We next explored the potential of the NSG mice model as a platform for testing drugs against P. falciparum 
transmission stages. Indeed, humanized mice have a crucial role for drug discovery in malaria, as they offer the 
opportunity to assess in vivo the activity of drugs. As a proof of concept, we studied the effect of primaquine, 
which is currently the only licensed drug that has demonstrated efficacy to eliminate P. falciparum gametocytes 
in humans24. A group of 4 mice were treated with primaquine (2 mg/kg; intraperitonealy) for 4 days, starting 1 
to 4 days after appearance of P. falciparum gametocytes in peripheral blood (Fig. 5a). In the 4 mice, with gameto-
cytemia ranging from 0.1% to 0.66% at day 0, gametocytes of all stages were totally eliminated from peripheral 
blood after 3 to 6 days of treatment. In contrast, in 10 untreated mice from 3 independent infection experiments, 
the average gametocytemia increased from 0.045% to 0.325% during the 9 days following appearance of gameto-
cytes in peripheral blood. As expected, asexual stages were also eliminated from peripheral blood after 3 to 6 days, 
since primaquine treatment at 2 mg/kg represents a dose 1000-fold upper the IC50 of primaquine on asexual 
stages25,26 (Supplemental Figure S1). In addition, the efficacy of primaquine to eliminate gametocytes from 
sequestration sites was evaluated in Giemsa-stained smears of bone marrow aspirates and spleen extracts and 
compared to the average of gametocytemia in 10 untreated mice (Fig. 5b,c). Gametocytes were totally eliminated 
from both organs in 3 treated mice, whereas one mouse still harbored a significant gametocytemia, corresponding 
to 10% (in bone marrow) and 16% (in spleen) of the initial gametocytemia in peripheral blood at day 0 of 
primaquine treatment. These data show that the immunosuppression protocol used to engraft mice does not 
interfere with the assessment of gametocytidal treatments and provides the proof of concept that this model is 
Figure 3. Gametocytes are enriched in the bone marrow and the spleen. (a) Histological sections of sternum 
bone marrow, spleen, liver and lung were stained with antibodies directed against Pfg27 and HSP70 to detect 
gametocytes and all parasites, respectively. n = total number of HSP70- and Pfg27-positive parasites observed 
in 30 fields at 630X magnification for each tissue sample for 5 mice (a total of 1, 200 fields was analyzed). Bars 
represent 10 μ m. (b) Proportion of Pfg27-positive gametocytes in the HSP70-positive parasite population in 
bone marrow (BM), spleen (SP), lung and liver. Results represent the average ratio of Pfg27-positive cells in 
Pfg27-stained sections to HSP70-positive cells in HSP70-stained sections observed in 30 fields. Stars represent 
significant differences in proportion (**P < 0.01, *P < 0.05). ns: not significant. (c) Quantitative analysis by real 
time RT-qPCR of gametocytes distribution in peripheral blood (PB), femur bone marrow (BM), spleen (SP), 
lung and liver. Relative copy numbers (RCN) of the gametocyte marker Pfs48/45 were calculated as the ratio 
between copy numbers of Pfs48/45 transcripts and the geometric mean of the ring upregulated gene sbp1 and 
the trophozoite upregulated gene hprt transcripts. Results represent the average quantification for 8 mice from 
two independent infection experiments. (d) Histological sections of bone marrow (sternum) were stained with 
antibodies directed against laminin to detect basement membrane of microvasculature (V). Hemozoin malaria 
pigment allows detection of parasites in intra- (green arrow) or extra- (yellow arrow) vascular space. Bars 
represent 10 μ m. (e) Proportion of intra- and extra-vascular parasites observed in a population of 200 parasites 
on laminin-stained histological sections from three mice.
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Figure 4. Immature gametocytes are enriched in the bone marrow and the spleen. (a) The proportion 
of gametocytes in peripheral blood, femur bone marrow aspirate or spleen extract was analyzed by 
immunostaining and determined by calculating the percentage of Pfg27-positive parasites in the total parasite 
population detected by Hoechst staining. Different developmental stages were determined by analysis of 
gametocyte morphology on differential interference contrast images. Bars represent 2 μ m. (b) Average 
proportion of gametocytes in the parasite population observed in peripheral blood (PB), bone marrow (BM) 
and spleen (SP). PB: 311 gametocytes observed in 12 mice, BM: 213 gametocytes observed in 12 mice, SP: 123 
gametocytes observed in 6 mice. (c) Average proportion of asexual stages, immature gametocytes and mature 
gametocytes in the parasite population observed in PB, BM and SP. (d) Average proportion of each gametocyte 
stage in the parasite population observed in PB, BM and SP. (b–d) Results represent the average proportion for 
12 mice (PB and BM) or 6 mice (SP) from four independent infection experiments. Stars represent significant 
differences in proportion (***P < 0.001, **P < 0.01, *P < 0.05). ns: not significant. Graphs were generated using 
GraphPad Prism software. Error bars represents Standard Error of the Mean (SEM).
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suitable for testing new drugs against P. falciparum transmission stages. Importantly, this protocol can be used to 
address the effect of a drug on the persistence of gametocytes in their sequestration sites, which is crucial infor-
mation that could not be provided by clinical trials in humans.
In summary, these humanized mice are a suitable model to investigate P. falciparum sexual commitment 
in vivo, gametocyte interactions with the bone marrow and the spleen, and they may facilitate the discovery of 
new gametocytidal drugs, which is urgently needed to achieve the goal of malaria eradication.
Methods
Ethics statements. This study was carried out in strict accordance with the guide for the care and use of 
laboratory animals from the Centre d’Expérimentation Fonctionnelle (CEF, La Pitié-Salpêtrière, Paris) and with 
the French and European regulations (2010/63/EU). The experimental protocols were approved by the Ministère 
de l′ Education Nationale, de l’Enseignement Supérieur et de la Recherche (Authorization Number 01737.03).
Immunomodulation treatment and mouse infection. NSG mice aged 9–11 weeks (Charles River, US) 
were bred at the CEF under strict pathogen-free conditions. They were provided with UV light-exposed commer-
cial food and autoclaved water ad libitum. Human red blood cells (hRBC) were obtained from donors without 
history of malaria (Etablissement Français du Sang Ile-de-France, Rungis). Before peritoneal injection into mice, 
hRBC were washed twice with RPMI-1640 medium (Gibco/BRL) at 900 g, 10 min at 25 °C. The depletion of tissue 
macrophages was induced by clodronate (Roche Diagnostics) encapsulated in liposomes (lip-clod) as described27. 
Neutrophils were depleted using the monoclonal antibody (mAb) NIMP-R14 produced by a hybridoma kindly 
provided by Dr M. Strath (National Institute for Medical Research, London, U.K.)28. To obtain the graft of hRBC 
and subsequent P. falciparum NF54 infection, each mouse received by intraperitoneal injection a dose of 1 mg/kg 
of mAb NIMP-R14 at day 0 and 6.25 mg/kg of lip-clod at day 1. At day 5 and day 7 each mouse received 1.5 mL 
of hRBC at 50% hematocrit in RPMI mixed with 1 mg/kg of mAb NIMP-R14 and 6.25 mg/kg of lip-clod. At day 
Figure 5. Humanized NSG mice provide a suitable model for testing malaria gametocytidal drugs.  
(a) Kinetics of gametocytemia for stage II, III, IV and V gametocytes in peripheral blood in 10 untreated mice 
(Control mice) and in 4 primaquine-treated mice during 8 to 11 days following appearance of gametocytes in 
peripheral blood (blue star). Gametocytemia (% of gametocytes in total RBCs) for each gametocyte stage were 
determined by counting parasites on Giemsa-stained thin blood smears. Primaquine treatment (2 mg/kg)  
was started 1 to 4 days after appearance of gametocytes and was daily administered for 4 days (red arrows). 
Mice were sacrificed seven days after beginning of treatment (black arrow). (b) Gametocytemia in bone 
marrow after sacrifice as observed in Giemsa-stained smears of bone marrow aspirate. Control represents an 
average of gametocytemia for 10 mice from three independent infection experiments. (c) Gametocytemia in 
spleen after sacrifice as observed in Giemsa-stained smears of crushed spleen. Control represents the average 
gametocytemia of 6 mice from two independent infection experiments.
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9 each mouse received the same doses of immunomodulators in 1.5 mL of hRBC at 50% hematocrit containing 
5.10e5 P. falciparum NF54 asexual parasites. Parasites used for infection were obtained from an in vitro culture 
maintained below 1.5% parasitemia to avoid in vitro induction of gametocytogenesis. After P. falciparum infec-
tion, mice were grafted with 1 to 1.5 mL of hRBC at 50% hematocrit containing 1 mg/kg of mAb NIMP-R14 and 
6.25 mg/kg of lip-clod every 2–3 days. Hematological parameters (hematocrit, leucocytes, platelets, percentage of 
hRBC in peripheral blood) were followed up during the assay in blood samples taken from mouse tails and ana-
lyzed with an automatic hematology analyzer (Scil Vet abc Plus, Scil Animal Care). Mice exhibiting hematocrit up 
to 60% and percentage of hRBC higher than 70% only received the graft of hRBC once the hematocrit decreased 
to 50%. Presence of residual hRBC in the peritoneum was assessed after sacrifice of the mice.
RT-qPCR analysis. Peripheral blood samples and femur bone marrow aspirate samples were added to 
Trizol (Life technologies) and vortexed. Spleen, liver and lung sections were processed through grinding in 
Trizol. RNA was prepared using the PureLink RNA Mini kit (Life technologies) and treated using on-column 
DNase-Treatment with Pure Link DNase (Life technologies). Quantity and purity of RNA were assessed with 
Epoch spectrophotometer. Contamination with genomic parasite DNA was assessed by qPCR with primers for 
P. falciparum seryl-tRNA synthetase (PF07_0073) and positive samples were retreated with DNAse and retested 
for lack of genomic DNA. RNA (100–200 ng for peripheral blood and total RNA for other organs) was used for 
complementary DNA (cDNA) synthesis with the SuperScript III First-Strand Synthesis System (Life technolo-
gies). Positive cDNA synthesis was confirmed by qPCR targeting P. falciparum seryl-tRNA synhtetase. Primers 
for the gametocyte marker Pfs48/45 (PF13_0247)2, the trophozoite upregulated gene hprt (PF10_0121)29 and the 
ring upregulated gene sbp1 (PFE0065w)29 were used to detect transcripts from gametocytes, trophozoites and 
rings, respectively (Supplemental Table S1). Final reaction volumes of 20 uL included 4 uL of cDNA (3–30 ng/uL) 
and 10 uL of Power SYBRGreen Master Mix (Applied Biosystems). qPCRs were performed in a ABi Prism 7500 
(Applied Biosystems) with 2 minutes at 50 °C, 10 minutes at 95 °C (1 cycle), 30 seconds at 95 °C, and 1 minute at 
60 °C (40 cycles). Each sample was analyzed in triplicate together with a serial dilution of 3D7 gDNA for absolute 
quantification of transcript copy numbers. To normalize for the level of parasitemia and amount of cDNA loaded 
in each reaction, relative copy numbers (RCN) were calculated as the ratio between copy numbers of Pfs48/45 
transcripts and the geometric mean of sbp1 and hprt transcripts.
Immunofluorescence assays. Thin smears of peripheral blood, femur bone marrow aspirate or spleen 
extract were air-dried and fixed for 10 minutes in methanol chilled at − 20 °C. Samples were incubated in 2% 
bovine serum albumin in PBS for 1 h at room temperature to block non-specific binding. The preparations 
were then incubated overnight at 4 °C with a rabbit polyclonal anti-Pfg27 antibody30 diluted 1/1000 and with 
AlexaFluor 594-conjugated goat anti-rabbit antibody (Molecular Probes) for 1 hour. Nuclei were stained with 
Hoechst 33342. Samples were observed at 1000X magnification using a Leica DM 5000 B. At least 50 fields at 
1000X magnification were analyzed for each sample.
Histology and immunohistochemistry. Samples were fixed in 10% neutral buffered formalin, embedded in 
paraffin and 4 μ m-thick sections were cut and stained with standard Hematoxylin-Eosin staining. In order to detect 
parasites, immunohistochemistry analyses were carried out using a mouse monoclonal anti-Plasmodium HSP70 
antibody31 at dilution 1/1000 and a rabbit polyclonal anti-Pfg27 antibody30 at 1/2000. Gametocyte enrichment 
in different organs was calculated as the ratio of Pfg27-positive cells in Pfg27-stained sections to HSP70-positive 
cells in HSP70-stained sections observed in 30 fields at 630X magnification for each tissue sample. To determine 
the location of parasites, indirect labeling of blood vessels was carried out using a rabbit anti-laminin polyclonal 
antibody (Sigma Aldrich, dilution 1:100) to detect basement membrane of microvasculature. Positive signal was 
revealed using Histofine Simple Stain MAX PO (mouse or rabbit depending on the primary antibody; Nichirei 
Biosciences Inc.) according to the manufacturer’s protocol. Color was developed with 3-Amino-9-EthylCarbazole 
(AEC chromogen; BD Pharmingen). Samples were observed at 630X magnification using a LEICA DM 400B.
Drug treatment. Primaquine (Sigma Aldrich) at 2 mg/kg in RPMI-1640 (Gibco, BRL) was administered 
daily by intraperitoneal injection during 4 days. Primaquine treatment was started 1 to 4 days after appearance 
of gametocytes in peripheral blood. For each mouse, gametocytemia was monitored in thin tail-blood smears 
collected daily until sacrifice at day 7 post drug treatment.
Statistical analysis. Statistical significance for differences in gametocyte proportions in different organs was 
established using Student’s t-test and Wilcoxon Mann-Whitney rank sum test.
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